AU3000292A - Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation - Google Patents

Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation

Info

Publication number: AU3000292A
Authority: AU; Australia
Prior art keywords: autoregulation; stabilizing; xanthine derivatives; cerebral circulation; cerebral
Prior art date: 1991-12-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU30002/92A

Inventor

John Grome

Ralf Kolvenbach

Ernst-Jurgen Schneider

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hoechst AG

Original Assignee

Hoechst AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-12-11

Filing date

1992-12-10

Publication date

1993-06-17

1992-12-10 Application filed by Hoechst AG filed Critical Hoechst AG

1993-06-17 Publication of AU3000292A publication Critical patent/AU3000292A/en

Status Abandoned legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU30002/92A 1991-12-11 1992-12-10 Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation Abandoned AU3000292A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4140805		1991-12-11
DE4140805		1991-12-11

Publications (1)

Publication Number	Publication Date
AU3000292A true AU3000292A (en)	1993-06-17

Family

ID=6446782

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU30002/92A Abandoned AU3000292A (en)	1991-12-11	1992-12-10	Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation

Country Status (10)

Country	Link
EP (1)	EP0547508A1 (en)
JP (1)	JPH05246850A (en)
KR (1)	KR930012020A (en)
AU (1)	AU3000292A (en)
CA (1)	CA2085046A1 (en)
HU (2)	HU9203909D0 (en)
IL (1)	IL104037A0 (en)
MX (1)	MX9207156A (en)
TW (1)	TW209834B (en)
ZA (1)	ZA929566B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5981536A (en) *	1996-07-31	1999-11-09	Hoechst Aktiengesellschaft	Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) *	1996-07-31	1999-01-05	Hoechst Aktiengesellschaft	Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH062675B2 (en) *	1985-04-05	1994-01-12	ヘキストジヤパン株式会社	Memory disorder treatment
DE3525801A1 (en) *	1985-07-19	1987-01-22	Hoechst Ag	TERTIA HYDROXYALKYLXANTHINE, METHOD FOR THE PRODUCTION THEREOF, THE MEDICINAL PRODUCT CONTAINING IT AND THEIR USE
DE3942871A1 (en) *	1989-12-23	1991-06-27	Hoechst Ag	R - (-) - 1- (5-HYDROXYHEXYL) -3-METHYL-7-PROPYLXANTHINE, METHOD OF ITS PREPARATION AND MEDICAMENTS CONTAINING THIS COMPOUND

1992
- 1992-07-25 TW TW081105887A patent/TW209834B/zh active
- 1992-12-09 IL IL104037A patent/IL104037A0/en unknown
- 1992-12-10 KR KR1019920023765A patent/KR930012020A/en not_active Application Discontinuation
- 1992-12-10 MX MX9207156A patent/MX9207156A/en unknown
- 1992-12-10 ZA ZA929566A patent/ZA929566B/en unknown
- 1992-12-10 HU HU9203909A patent/HU9203909D0/en unknown
- 1992-12-10 CA CA002085046A patent/CA2085046A1/en not_active Abandoned
- 1992-12-10 JP JP4330129A patent/JPH05246850A/en active Pending
- 1992-12-10 AU AU30002/92A patent/AU3000292A/en not_active Abandoned
- 1992-12-10 HU HU9203909A patent/HUT62799A/en unknown
- 1992-12-10 EP EP92121076A patent/EP0547508A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
MX9207156A (en)	1993-06-01
TW209834B (en)	1993-07-21
KR930012020A (en)	1993-07-20
JPH05246850A (en)	1993-09-24
HU9203909D0 (en)	1993-03-29
ZA929566B (en)	1993-06-16
CA2085046A1 (en)	1993-06-12
EP0547508A1 (en)	1993-06-23
IL104037A0 (en)	1993-05-13
HUT62799A (en)	1993-06-28

Similar Documents

Publication	Publication Date	Title
ZA917610B (en)	1992-09-30	Xanthine derivatives
GB9127279D0 (en)	1992-02-19	Heterocyclic derivatives
GB9225283D0 (en)	1993-01-27	Heterocyclic derivatives
AU4457089A (en)	1990-05-31	Hydrate forms of 1-carbacephalosporin derivatives
GB9124733D0 (en)	1992-01-15	Derivatives of poly-4-amino-2-carboxy-1-methyl compounds
GB9102804D0 (en)	1991-03-27	Heterocyclic derivatives
HU9501397D0 (en)	1995-06-28	Xanthine derivatives for use as diuretics
AU3000292A (en)	1993-06-17	Use of xanthine derivatives for stabilizing autoregulation of cerebral circulation
IL120997A0 (en)	1997-11-20	Use of theophylline derivatives for the treatment and prophylaxis of states of shock novel xanthine compounds and processes for their preparation
GB2275927B (en)	1995-10-04	Process for the preparation of cephem derivatives
AU3793089A (en)	1990-01-11	THAZ derivatives for enhancement of cerebral function
GB9121205D0 (en)	1991-11-20	Derivatives of poly-5-amino-3-carboxy-1-methyl compounds
EP0556778A3 (en)	1993-11-24	Xanthine derivatives
EP0519370A3 (en)	1993-03-17	Heterocyclic derivatives
EP0468927A3 (en)	1992-11-19	Derivatives of carboxymethylcyclopropane
HU9400358D0 (en)	1994-05-30	Use of quinoziline derivatives as orexigenics
GB8708347D0 (en)	1987-05-13	Derivatives of polyhydroxy compounds
IL109229A0 (en)	1994-07-31	Heterocyclic compounds and processes for the preparation of pyranyl cyanoguanidine derivatives using the same
ZA893931B (en)	1990-02-28	Process for the preparation of pyrrolizine derivatives
EP0501511A3 (en)	1993-04-21	Processes for preparation of nucleoside derivatives
CS56288A1 (en)	1989-09-12	Derivatives of adenine
BG98208A (en)	1994-05-27	Derivatives of cephalosporin
GB9107573D0 (en)	1991-05-29	New derivatives of poly-4-amino-2-carboxy-1-methyl compounds
ZA923478B (en)	1993-02-24	Heterocyclic derivatives
GB9103874D0 (en)	1991-04-10	Heterocyclic derivatives